Zaloguj się
prof. dr hab. Gabriel Nowak
prof. dr hab. Gabriel Nowak
+48 12 6623215
nowak@if-pan.krakow.pl
pokój Ojcowska 
Zakład NeurobiologiiDokonania naukowe
- Publikacje
Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: Behavioral and pharmacokinetic studies in mice
Autorzy: Poleszak, E., Wlaź, P., Szewczyk, B., Kȩdzierska, E., Wyska, E., Librowski, T., Szymura-Oleksiak, J., Fidecka, S., Pilc, A., Nowak, G.
DOI: 10.1016/j.pbb.2005.03.017
Date: 2005-01-01
GABAergic hypotheses of anxiety and depression: Focus on GABA<inf>B</inf> receptors
Autorzy: Pilc, A., Nowak, G.
DOI: 10.1358/dot.2005.41.11.904728
Date: 2005-01-01
Erratum: Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor antagonist does not involve GABA<inf>A</inf> signaling (Neuropharmacology (2004) 47 (342-350) PII: 10.1016/j.neuropharm.2004.04.013)
Autorzy: Klodzinska, A., Tatarczyńska, E., Chojnacka-Wójcik, E., Nowak, G., Cosford, N.D.P., Pilc, A.
DOI: 10.1016/j.neuropharm.2004.08.006
Date: 2004-01-01
Effect of chronic treatment with dexamethasone on brain dopamine receptors in mice
Autorzy: Wróbel, A., Nowak, G., Ossowska, G., Danilczuk, Z., Zebrowska-Łupina, I., Wielosz, M.
DOI:
Date: 2004-01-01
Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT<inf>1A</inf> and 5-HT<inf>2A</inf> receptors, part 2
Autorzy: Herold, F., Kleps, J., Nowak, G., Maj, M.
DOI:
Date: 2004-01-01
Pharmacokinetic interaction after joint administration of zinc and imipramine in forced swim test in mice
Autorzy: Wyska, E., Szymura-Oleksiak, J., Opoka, W., Baś, B., Niewiara, E., Pomierny, L., Dybała, M., Nowak, G.
DOI:
Date: 2004-01-01
Effect of Imipramine treatment on plasma dopamine beta-hydroxylase activity in chronic mild stress in rats
Autorzy: Grabowska, M., Schlegel-Zawadzka, M., Papp, M., Nowak, G.
DOI:
Date: 2004-01-01
New Arylpiperazine 5-HT<inf>1A</inf> Receptor Ligands Containing the Pyrimido[2,1-f]purine Fragment: Synthesis, in Vitro, and in Vivo Pharmacological Evaluation
Autorzy: Jurczyk, Sł., Kołaczkowski, M., Maryniak, E., Zajdel, P., Pawłowski, M., Tatarczyńska, E., Kłodzińska, A., Chojnacka-Wójcik, E., Bojarski, A.J., Charakchieva-Minol, S., Duszyńska, B., Nowak, G., Macia̧g, D.
DOI: 10.1021/jm030946u
Date: 2004-01-01
Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA<inf>A</inf> signaling
Autorzy: Klodzinska, A., Tatarczyńska, E., Chojnacka-Wójcik, E., Nowak, G., Cosford, N.D.P., Pilc, A.
DOI: 10.1016/j.neuropharm.2004.04.013
Date: 2004-01-01
Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats
Autorzy: Pałucha, A., Tatarczyńska, E., Brański, P., Szewczyk, B., Wierońska, J.M., Kłak, K., Chojnacka-Wójcik, E., Nowak, G., Pilc, A.
DOI: 10.1016/j.neuropharm.2003.09.006
Date: 2004-01-01
